Rankings
▼
Calendar
PCRX FY 2018 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena
PCRX
Pacira BioSciences, Inc.
$969M
FY 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$337M
+17.7% YoY
Gross Profit
$250M
74.3% margin
Operating Income
$16M
4.7% margin
Net Income
-$471,000
-0.1% margin
EPS (Diluted)
$-0.01
Cash Flow
Operating Cash Flow
$49M
Free Cash Flow
$34M
Stock-Based Comp.
$32M
Balance Sheet
Total Assets
$689M
Total Liabilities
$368M
Stockholders' Equity
$321M
Cash & Equivalents
$133M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$337M
$287M
+17.7%
Gross Profit
$250M
$199M
+26.0%
Operating Income
$16M
-$25M
+163.8%
Net Income
-$471,000
-$43M
+98.9%
← Q4 2017
All Quarters
Q1 2018 →